Mar 24, 2021
The Tuberculosis and New Entrant Assessment Team provides screenings for people who may be at risk of contracting tuberculosis.
Early diagnosis and treatment is important for active TB
seen from New Zealand
seen from Australia
seen from China
seen from United States
seen from Taiwan
seen from New Zealand
seen from Switzerland
seen from China
seen from China
seen from Australia
seen from United States
seen from China
seen from Türkiye
seen from United States
seen from United States
seen from Malaysia
seen from United States
seen from United States
seen from United States
seen from China
The Tuberculosis and New Entrant Assessment Team provides screenings for people who may be at risk of contracting tuberculosis.
Early diagnosis and treatment is important for active TB
The Union is a global scientific organisation with the mission to improve health among people...
LEADING THE FIGHT AGAINST TB AND LUNG DISEASE
Behavioral and Social Science Research
Behavioral and social science research has the potential to make a tremendous impact on TB elimination efforts. This research is needed to 1) understand how behaviors of both patients and providers affect TB-related care seeking, diagnosis, treatment success, and prevention; and 2) understand how other social, cultural, and environmental influences affect health seeking and treatment outcomes related to TB.
TB Trials Consortium (TBTC)
The TB Trials Consortium (TBTC) is a collaboration of North American and international clinical investigators whose mission is to conduct programmatically relevant research concerning the diagnosis, clinical management, and prevention of TB infection and disease.
The TB Epidemiologic Studies Consortium (TBESC)
The TB Epidemiologic Studies Consortium (TBESC) was established to strengthen, focus, and coordinate tuberculosis (TB) research. The TBESC is designed to build the scientific research capacities of state and metropolitan TB control programs, participating laboratories, academic institutions, hospitals, and both non- and for-profit organizations.
US$ 2 billion invested in more than 100 countries since 2002 – The Global Fund to Fight AIDS, Tuberculosis and Malaria is playing a major role in transforming global TB efforts, enabling an increasing number of people around the world to access good quality diagnosis and treatment of TB, including multidrug-resistant (MDR)-TB. By the end of 2011, programmes supported by the Global Fund detected and treated 8.6 million people with TB.